Published in Gut on March 01, 2006
Synbiotic Treatment in Crohn's Disease Patients | NCT00305409
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ (2010) 4.69
Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One (2012) 1.82
Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease. World J Gastroenterol (2009) 1.77
Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics (2006) 1.67
Characteristics of inflammatory bowel disease serology in patients with indeterminate colitis. J Clin Gastroenterol (2014) 1.39
A prospective randomized comparison between two MRI studies of the small bowel in Crohn's disease, the oral contrast method and MR enteroclysis. Eur Radiol (2007) 1.32
Current treatment of ulcerative colitis. World J Gastroenterol (2011) 1.17
Association between red cell distribution width and disease activity in patients with inflammatory bowel disease. Dig Dis Sci (2011) 1.17
Follow-up endoscopy in gastroenterology: when is it helpful? Dtsch Arztebl Int (2010) 1.13
Crohn's disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci (2008) 1.08
The diagnosis and treatment of Crohn's disease and ulcerative colitis. Dtsch Arztebl Int (2009) 1.07
Magnetic resonance imaging for evaluation of disease activity in Crohn's disease: a systematic review. Eur Radiol (2009) 1.02
Quantified terminal ileal motility during MR enterography as a potential biomarker of Crohn's disease activity: a preliminary study. Eur Radiol (2012) 1.01
Frequency and nature of incidental extra-enteric lesions found on magnetic resonance enterography (MR-E) in patients with inflammatory bowel diseases (IBD). PLoS One (2009) 0.97
Medical management of Crohn's disease. BMJ (2008) 0.97
Association between toll-like receptors/CD14 gene polymorphisms and inflammatory bowel disease in Korean population. J Korean Med Sci (2011) 0.96
NOD2 status and human ileal gene expression. Inflamm Bowel Dis (2010) 0.96
Magnetic resonance enterography in Crohn's disease: Standard and advanced techniques. World J Radiol (2010) 0.96
Magnetization transfer for the assessment of bowel fibrosis in patients with Crohn's disease: initial experience. MAGMA (2012) 0.94
Inflammatory bowel disease unclassified. J Zhejiang Univ Sci B (2011) 0.94
Use of small bowel imaging for the diagnosis and staging of Crohn's disease--a survey of current UK practice. Br J Radiol (2010) 0.93
The history of genetics in inflammatory bowel disease. Ann Gastroenterol (2014) 0.92
Plasma citrulline as surrogate marker of intestinal inflammation in pediatric and adolescent with Crohn's disease: preliminary report. Int J Colorectal Dis (2011) 0.92
Comparison of sonographically measured bowel wall vascularity, histology, and disease activity in Crohn's disease. Eur Radiol (2009) 0.91
Serum metabolic profiling in inflammatory bowel disease. Dig Dis Sci (2012) 0.91
Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics. Eur J Health Econ (2014) 0.90
Inflammatory bowel disease in the dog: differences and similarities with humans. World J Gastroenterol (2010) 0.90
Infliximab induces clonal expansion of γδ-T cells in Crohn's disease: a predictor of lymphoma risk? PLoS One (2011) 0.90
Detection of inflammatory bowel disease: diagnostic performance of cross-sectional imaging modalities. Abdom Imaging (2008) 0.89
Postoperative Crohn's disease recurrence: a practical approach. World J Gastroenterol (2008) 0.88
Clinical applications of small bowel capsule endoscopy. Clin Exp Gastroenterol (2013) 0.88
Fatigue severity and factors associated with high fatigue levels in Korean patients with inflammatory bowel disease. Gut Liver (2013) 0.88
Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis. PLoS One (2011) 0.87
Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease. BMC Gastroenterol (2012) 0.86
Histological healing in inflammatory bowel disease: a still unfulfilled promise. World J Gastroenterol (2013) 0.86
Computed tomography enterography for evaluation of inflammatory bowel disease. Clin Endosc (2013) 0.86
Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study. BMC Gastroenterol (2009) 0.85
The role of the Rho/Rock signaling pathway in the pathogenesis of acute ischemic myocardial fibrosis in rat models. Exp Ther Med (2013) 0.85
Deficit of gammadelta T lymphocytes in the peripheral blood of patients with Crohn's disease. Dig Dis Sci (2011) 0.84
Risk factors for repeat abdominal surgery in korean patients with Crohn's disease: a multi-center study of a korean inflammatory bowel disease study group. J Korean Soc Coloproctol (2012) 0.84
Magnetic resonance imaging in Crohn's disease. BMJ (2008) 0.84
The association between race and Crohn's disease phenotype in the Western Cape population of South Africa, defined by the Montreal Classification System. PLoS One (2014) 0.84
Contrast Enhanced Abdominal Ultrasound in the Assessment of Ileal Inflammation in Crohn's Disease: A Comparison with MR Enterography. PLoS One (2015) 0.83
Clinical outcomes and predictive factors for response after the first course of corticosteroid therapy in patients with Crohn's disease. Gut Liver (2013) 0.83
Health determining concepts important to people with Crohn's disease and their coverage by patient-reported outcomes of health and wellbeing. J Crohns Colitis (2013) 0.83
Serological markers of inflammatory bowel disease. Biochem Med (Zagreb) (2013) 0.83
Is early limited surgery associated with a more benign disease course in Crohn's disease? World J Gastroenterol (2013) 0.83
Second Korean guidelines for the management of Crohn's disease. Intest Res (2017) 0.82
Age-dependent fecal bacterial correlation to inflammatory bowel disease for newly diagnosed untreated children. Gastroenterol Res Pract (2013) 0.82
Nutrient intake and bone mineral density by nutritional status in patients with inflammatory bowel disease. J Bone Metab (2014) 0.81
Dental caries, prevalence and risk factors in patients with Crohn's disease. PLoS One (2014) 0.81
Oral Manifestations of Crohn's Disease: A Case Report and Review of the Literature. Case Rep Dent (2015) 0.80
Clinical profiles of moderate and severe Crohn's disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines. Ann Gastroenterol (2015) 0.80
Soluble transferrin receptor-ferritin index in the evaluation of anemia in inflammatory bowel disease: a case-control study. Ann Gastroenterol (2011) 0.80
The association between childhood environmental exposures and the subsequent development of Crohn's disease in the Western Cape, South Africa. PLoS One (2014) 0.80
Crohn's-like enterocolitis associated with mycophenolic acid treatment. Gut (2008) 0.80
Inflammatory bowel diseases: the paediatric gastroenterologist's perspective. Pediatr Radiol (2007) 0.80
Small-bowel capsule endoscopy in patients with suspected Crohn's disease-diagnostic value and complications. Diagn Ther Endosc (2010) 0.80
Inhibitory effects of resistant starch (RS3) as a carrier for stachyose on dextran sulfate sodium-induced ulcerative colitis in C57BL/6 mice. Exp Ther Med (2013) 0.80
Low bone mineral density in Greek patients with inflammatory bowel disease: prevalence and risk factors. Ann Gastroenterol (2011) 0.80
Hyperhomocysteinemia in patients with Crohn's disease. Tech Coloproctol (2013) 0.80
Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery? World J Gastroenterol (2014) 0.80
Endoscopic Diagnosis and Differentiation of Inflammatory Bowel Disease. Clin Endosc (2016) 0.80
Differences in the location and activity of intestinal Crohn's disease lesions between adult and paediatric patients detected with MRI. Eur Radiol (2012) 0.79
When Crohn's disease is in remission, more patients complete capsule endoscopy study but less lesions are identified. Saudi J Gastroenterol (2013) 0.79
CARD15 mutations and perianal fistulating Crohn's disease: correlation and predictive value of antibiotic response. Dig Dis Sci (2010) 0.79
Immunomodulation does not alter histology in resected Crohn's disease. Tech Coloproctol (2009) 0.79
N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study. World J Gastroenterol (2008) 0.79
Non-adherence to Anti-TNF Therapy is Associated with Illness Perceptions and Clinical Outcomes in Outpatients with Inflammatory Bowel Disease: Results from a Prospective Multicentre Study. J Crohns Colitis (2016) 0.79
Roles of double-balloon endoscopy in the diagnosis and treatment of Crohn's disease: a multicenter experience. J Gastroenterol (2010) 0.79
DEFB1 gene 5' untranslated region (UTR) polymorphisms in inflammatory bowel diseases. Clinics (Sao Paulo) (2012) 0.78
Clinical epidemiology and phenotypic characteristics of Crohn's disease in the central region of Saudi Arabia. Saudi J Gastroenterol (2014) 0.78
Development of a new occupational balance-questionnaire: incorporating the perspectives of patients and healthy people in the design of a self-reported occupational balance outcome instrument. Health Qual Life Outcomes (2014) 0.78
Fluorescent quantitative PCR of Mycobacterium tuberculosis for differentiating intestinal tuberculosis from Crohn's disease. Braz J Med Biol Res (2014) 0.78
Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective. Mol Cell Proteomics (2015) 0.78
Assessing patients' satisfaction with anti-TNFα treatment in Crohn's disease: qualitative steps of the development of a new questionnaire. Clin Exp Gastroenterol (2011) 0.78
Antiglycan antibodies in Greek patients with inflammatory bowel disease. Dig Dis Sci (2010) 0.78
Long-term follow-up of nonspecific small bowel ulcers with a benign course and no requirement for surgery: is this a distinct group? BMC Gastroenterol (2011) 0.78
Are alterations of tight junctions at molecular and ultrastructural level different in duodenal biopsies of patients with celiac disease and Crohn's disease? Virchows Arch (2014) 0.77
Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870). Int J Nanomedicine (2007) 0.77
Fecal Calprotectin is an Accurate Tool and Correlated to Seo Index in Prediction of Relapse in Iranian Patients With Ulcerative Colitis. Iran Red Crescent Med J (2015) 0.77
Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease. World J Gastroenterol (2015) 0.77
Divergent neuroendocrine responses to localized and systemic inflammation. Semin Immunol (2014) 0.76
Role of wireless capsule endoscopy in inflammatory bowel disease. World J Gastrointest Endosc (2010) 0.76
Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012. World J Gastroenterol (2015) 0.76
Enteroscopy in small bowel Crohn's disease: A review. World J Gastrointest Endosc (2013) 0.76
Leukocyte-technetium-99m uptake in Crohn's disease: does it show subclinical disease? World J Gastroenterol (2010) 0.76
Advances in the Endoscopic Assessment of Inflammatory Bowel Diseases: Cooperation between Endoscopic and Pathologic Evaluations. J Pathol Transl Med (2015) 0.76
The Role of Laboratory Tests in Crohn's Disease. Clin Med Insights Gastroenterol (2016) 0.76
Epstein-Barr virus is related with 5-aminosalicylic acid, tonsillectomy, and CD19(+) cells in Crohn's disease. World J Gastroenterol (2015) 0.76
European evidence-based consensus on the diagnosis and management of Crohn's disease. Gut (2007) 0.76
Bayesian Machine Learning Techniques for revealing complex interactions among genetic and clinical factors in association with extra-intestinal Manifestations in IBD patients. AMIA Annu Symp Proc (2017) 0.75
Distinct features of circulating microparticles and their relationship with disease activity in inflammatory bowel disease. Ann Gastroenterol (2016) 0.75
A Retrospective Evaluation of the Utility of Capsule Endoscopy and Double-Balloon Endoscopy in Crohn's Disease. Gastroenterol Res Pract (2015) 0.75
Functional Toll-Like Receptor (TLR)2 polymorphisms in the susceptibility to inflammatory bowel disease. PLoS One (2017) 0.75
The Urgency of Neuroimaging Among UK Neuro-Ophthalmologists: Consensus and Disagreement. Neuroophthalmology (2013) 0.75
Accuracy of 99mTc (V)-Dimercaptosuccinic Acid Scintigraphy and Fecal Calprotectin Compared with Colonoscopy in Localizing Active Lesions in Inflammatory Bowel Disease. Middle East J Dig Dis (2016) 0.75
Multidetector CT Enterography versus Double-Balloon Enteroscopy: Comparison of the Diagnostic Value for Patients with Suspected Small Bowel Diseases. Gastroenterol Res Pract (2015) 0.75
Ultrasonographic findings in Crohn's disease. J Ultrasound (2014) 0.75
Anti-cyclic citrullinated peptide antibodies in ulcerative colitis, and its relation with disease activity. Med J Islam Repub Iran (2014) 0.75
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology (2004) 14.78
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet (2002) 14.14
Consensus methods: characteristics and guidelines for use. Am J Public Health (1984) 11.53
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet (2001) 7.27
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet (2004) 5.83
Inflammatory bowel disease (1) N Engl J Med (1991) 5.78
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet (2002) 5.31
Predictability of the postoperative course of Crohn's disease. Gastroenterology (1990) 5.30
Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology (1975) 4.66
Granulomatous diseases of the intestine. Lancet (1959) 4.25
Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut (2001) 4.23
The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology (2002) 4.20
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology (2002) 4.20
Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med (1986) 4.18
Guidelines for the management of inflammatory bowel disease in adults. Gut (2004) 4.15
Diagnosing small bowel Crohn's disease with wireless capsule endoscopy. Gut (2003) 3.69
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology (2000) 3.49
Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet (1993) 3.42
Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet (2004) 3.19
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology (1994) 2.85
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. Gastroenterology (1999) 2.80
The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology (2002) 2.78
Wireless capsule video endoscopy is a superior diagnostic tool in comparison to barium follow-through and computerized tomography in patients with suspected Crohn's disease. Eur J Gastroenterol Hepatol (2003) 2.70
A prospective randomized comparison between small bowel enteroclysis and small bowel follow-through in Crohn's disease. Gastroenterology (1997) 2.68
Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology (2002) 2.66
Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology (2003) 2.62
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology (1999) 2.62
Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'. J Clin Pathol (1978) 2.56
Transabdominal bowel sonography for the detection of intestinal complications in Crohn's disease. Gut (1999) 2.51
Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut (1988) 2.51
Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest (1982) 2.48
Microscopic activity in ulcerative colitis: what does it mean? Gut (1991) 2.43
Capsule endoscopy in patients with suspected Crohn's disease and negative endoscopy. Endoscopy (2003) 2.36
Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease. Lancet (1999) 2.29
Numerical taxonomy and discriminant analysis applied to non-specific colitis. Q J Med (1973) 2.26
Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol (2004) 2.24
An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut (1973) 2.21
Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease. Gastroenterology (1997) 2.18
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology (2002) 2.15
Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet (2002) 2.12
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol (2001) 2.06
Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging (2000) 1.93
C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis (2004) 1.92
Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol (2000) 1.92
Clinical uniformity of inflammatory bowel disease a presentation and during the first year of disease in the north and south of Europe. EC-IBD Study Group. Eur J Gastroenterol Hepatol (1997) 1.85
Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology (1995) 1.80
CT features of ulcerative colitis and Crohn's disease. AJR Am J Roentgenol (1996) 1.79
Granulomatous ulcerative colitis: a re-appraisal of the mucosal granuloma in the distinction of Crohn's disease from ulcerative colitis. Histopathology (2002) 1.76
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology (2001) 1.71
Recurrence after surgery in Crohn's disease. Relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology (1985) 1.70
From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology (2004) 1.68
Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut (1994) 1.64
Assessment of small bowel Crohn disease: noninvasive peroral CT enterography compared with other imaging methods and endoscopy--feasibility study. Radiology (2003) 1.63
Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther (2000) 1.61
MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol (2001) 1.60
Reliability and role of plain film radiography and CT in the diagnosis of small-bowel obstruction. AJR Am J Roentgenol (1996) 1.57
Perioperative endoscopy of the whole small bowel in Crohn's disease. Gut (1993) 1.54
Conflicting results of ileoscopy and small bowel double-contrast barium examination in patients with Crohn's disease. Endoscopy (1998) 1.53
A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease. Gastroenterology (2004) 1.51
Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. Gut (1991) 1.50
Contrast-enhanced power Doppler ultrasound in the diagnosis and follow-up of inflammatory abdominal masses in Crohn's disease. Eur J Gastroenterol Hepatol (2003) 1.49
Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease. Am J Gastroenterol (1999) 1.43
Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc (1995) 1.41
Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol (1993) 1.40
A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology (1986) 1.37
Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg (1992) 1.36
Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology (1987) 1.35
Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis. Scand J Gastroenterol (1999) 1.33
Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology (2000) 1.32
The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study. J Clin Gastroenterol (1988) 1.31
[Proposal of a system of criteria for the diagnosis of cryptogenetic inflammatory enterocolitis (Crohn's disease and hemorrhagic rectocolitis). A cooperative study by the Cryptogenic Enterocolitis Study Group]. Gastroenterol Clin Biol (1978) 1.30
A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation. Scand J Gastroenterol (1994) 1.30
Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets. Am J Dig Dis (1966) 1.28
Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology (1997) 1.27
The pathological diagnosis and differential diagnosis of Crohn's disease. Hepatogastroenterology (1990) 1.27
What is colitis? Statistical approach to distinguishing clinically important inflammatory change in rectal biopsy specimens. J Clin Pathol (1988) 1.23
Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol (2004) 1.22
C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders. Clin Chim Acta (1985) 1.22
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther (1994) 1.22
Indications for investigation of chronic gastrointestinal symptoms. Arch Dis Child (1995) 1.21
Is routine ileoscopy useful? An observational study of procedure times, diagnostic yield, and learning curve. Am J Gastroenterol (2004) 1.20
The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology (2002) 1.20
Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther (1994) 1.18
Optimization of oral contrast agents for MR imaging of the small bowel. Radiology (2003) 1.18
Crohn's disease of the upper gastrointestinal tract. Neth J Med (1997) 1.14
Crohn's disease evaluation: comparison of contrast-enhanced MR imaging and single-phase helical CT scanning. J Magn Reson Imaging (2000) 1.12
Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time. Am J Surg Pathol (1998) 1.11
Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of inflammatory bowel disease? Am J Gastroenterol (1998) 1.11
A clinicopathologic study of 42 patients with granulomatous gastritis. Is there really an "idiopathic" granulomatous gastritis? Am J Surg Pathol (1996) 1.10
Multiplanar helical CT enterography in patients with Crohn's disease. AJR Am J Roentgenol (1997) 1.08
The importance of diagnostic accuracy in colonic inflammatory bowel disease. Am J Gastroenterol (2000) 1.07
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut (2006) 8.08
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis (2010) 6.75
Predictability of the postoperative course of Crohn's disease. Gastroenterology (1990) 5.30
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (1996) 4.54
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study. Gut (2008) 4.41
Guidelines for the management of inflammatory bowel disease in adults. Gut (2004) 4.15
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology (1998) 4.08
Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology (1998) 3.82
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut (2004) 3.80
Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays. Aliment Pharmacol Ther (2012) 3.59
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy. Gut (2009) 3.50
Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology (1995) 3.44
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis (2009) 3.22
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology (1992) 3.17
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort. Gut (2008) 3.14
Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med (1998) 3.13
European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis (2013) 3.01
Anaemia in inflammatory bowel disease: a population-based 10-year follow-up. Aliment Pharmacol Ther (2013) 2.90
Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol (1999) 2.88
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology (1993) 2.83
Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol (2006) 2.81
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology (2001) 2.81
Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet (1995) 2.81
Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology (2002) 2.80
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. Gastroenterology (1999) 2.80
Yersinia enteritis and enterocolitis: gastroenterological aspects. Gastroenterology (1977) 2.79
Non-alcoholic duct destructive chronic pancreatitis. Gut (1997) 2.79
Appendectomy protects against ulcerative colitis. Gastroenterology (1994) 2.71
Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut (1984) 2.70
Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors. Aliment Pharmacol Ther (2012) 2.67
Microscopic colitis with giant cells. Histopathology (2002) 2.64
Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: results from a nationwide study. Endoscopy (2012) 2.58
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut (2004) 2.55
Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology (1991) 2.53
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut (2010) 2.47
Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology (1999) 2.46
Anatomy of Denonvilliers' fascia and pelvic nerves, impotence, and implications for the colorectal surgeon. Br J Surg (2000) 2.45
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood (2001) 2.40
Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis. Aliment Pharmacol Ther (2015) 2.25
Meta-analysis: The treatment of irritable bowel syndrome. Aliment Pharmacol Ther (2004) 2.23
Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol (1997) 2.20
Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease. Gastroenterology (1997) 2.18
European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis (2008) 2.14
Management of early rectal cancer. Br J Surg (2008) 2.13
Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease. Int J Clin Pract (2010) 2.12
Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun (2003) 2.10
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis. Gut (2009) 2.08
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol (2001) 2.06
Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther (2006) 2.06
Inflammatory mediators and cytokines--new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology (1993) 2.04
Predicting relapse in Crohn's disease: a biopsychosocial model. Gut (2008) 2.01
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis (2008) 1.99
Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol (1999) 1.97
A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab (2001) 1.97
Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut (2005) 1.95
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun (2001) 1.94
Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease. Aliment Pharmacol Ther (2001) 1.94
The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Gut (2005) 1.91
Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology (2001) 1.88
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease. Aliment Pharmacol Ther (2004) 1.87
Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology (1997) 1.84
Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial. Endoscopy (1998) 1.83
Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. J Clin Oncol (2000) 1.77
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol (1999) 1.77
ESPEN guidelines on nutrition in acute pancreatitis. European Society of Parenteral and Enteral Nutrition. Clin Nutr (2002) 1.75
Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut (1996) 1.73
Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther (2009) 1.72
Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans. Gastroenterology (1992) 1.72
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis (2012) 1.71
Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease. Eur J Clin Invest (1999) 1.71
Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut (1999) 1.69
Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study. Am J Gastroenterol (1997) 1.69
Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology (1997) 1.69
Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology (1999) 1.68
Isolation and phenotypic characterization of colonic macrophages. Clin Exp Immunol (1998) 1.68
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis (2013) 1.67
Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta (2005) 1.66
Local excision of rectal tumours by transanal endoscopic microsurgery. Br J Surg (2007) 1.66
Cheilitis granulomatosa and Melkersson-Rosenthal syndrome: evaluation of gastrointestinal involvement and therapeutic regimens in a series of 14 patients. J Eur Acad Dermatol Venereol (2007) 1.65
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Performance of panel-based criteria to evaluate the appropriateness of colonoscopy: a prospective study. Gastrointest Endosc (1998) 1.64
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. J Crohns Colitis (2014) 1.62
Detection of dysplastic lesions by fluorescence in a model of colitis in rats after previous photosensitization with 5-aminolaevulinic acid. Endoscopy (1998) 1.62